Friday, September 27, 2019
Noon-1:30 p.m.
Hart Senate Office Building, Room 216
120 Constitution Ave NE, Washington, DC
Complimentary lunch and networking will begin at 11:30 a.m.
THIS EVENT IS OPEN TO THE PUBLIC. Panelists will be speaking on the record.
While pharmaceutical innovation has resulted in treatments–and in some cases, cures–for debilitating diseases, high prescription drug prices have precluded access for many people in the U.S. This fall, Congress and the administration are poised to consider many policies to reform the prescription drug market and reduce prices paid by consumers as well as public and private payers. During this briefing, panelists will discuss components of policy proposals under consideration and explore evidence about their implications for the health care system.
Panelists
-
Kirsten Axelsen, M.S., Visiting Fellow, American Enterprise Institute
-
Kristi Martin, M.A., MPA, Senior Vice President, Waxman Strategies
-
James C. Robinson, Ph.D., MPH, Leonard D. Schaeffer Endowed Chair in Health Economics and Policy; Director, Berkeley Center for Health Technology; Division Head, Health Policy & Management, UC Berkeley School of Public Health
-
Moderated by: Lovisa Gustafsson, MBA, Assistant Vice President, The Commonwealth Fund
**The panel may change due to the addition of speakers**
You will need to go through security to enter the building.
Please register by Thursday, September 26 at 4 p.m. to ensure the availability of event materials.